4/8
08:00 am
fbrx
Forte Biosciences, Inc. (NASDAQ: FBRX) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating. They now have a $2.75 price target on the stock.
Medium
Report
Forte Biosciences, Inc. (NASDAQ: FBRX) was upgraded by analysts at LADENBURG THALM/SH SH from a "neutral" rating to a "buy" rating. They now have a $2.75 price target on the stock.
3/18
04:05 pm
fbrx
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
Low
Report
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update